Benzinga - by Avi Kapoor, Benzinga Staff Writer.
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.
Tecogen
- The Trade: Tecogen Inc. (OTC:TGEN) Director Earl R Lewis bought a total of 10,000 shares at an average price of $0.68. To acquire these shares, it cost around $6,800. The company's Director John Hatsopoulos also bought 5,000 shares.
- What's Happening: Tecogen is expected to release first-quarter financial results on Thursday, May 9.
- What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.
- The Trade: Bespoke Extracts, Inc. (OTC:BSPK) CEO Michael Feinsod acquired a total of 5,000 shares at an average price of $0.11. To acquire these shares, it cost around $550.
- What's Happening: The company's stock lost around 22% over the past six months.
- What Bespoke Extracts Does: Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products.
- The Trade: GlucoTrack, Inc. (NASDAQ:GCTK) Director Drew Sycoff acquired a total of 182,540 shares at an average price of $1.26. The insider spent around $230,000 to buy those shares.
- What's Happening: GlucoTrack recently announced closing of private placement.
- What GlucoTrack Does: GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.